These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM, White CM, Coleman CI. Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [Abstract] [Full Text] [Related]
3. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable? Gunen H, Mirici A, Meral M, Akgün M. Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028 [Abstract] [Full Text] [Related]
8. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Tashkin DP. Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901 [Abstract] [Full Text] [Related]
10. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. Pujades-Rodríguez M, Smith CJ, Hubbard RB. QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226 [Abstract] [Full Text] [Related]
11. Systemic corticosteroids for acute exacerbations of COPD. Ebell MH. Am Fam Physician; 2005 Aug 01; 72(3):437-8. PubMed ID: 16100857 [No Abstract] [Full Text] [Related]
12. [Efficacy of anti-inflammatory treatment with benacort in exacerbations of chronic obstructive lung disease]. Kolesnikov VV, Korol'chuk IS. Ter Arkh; 2003 Aug 01; 75(1):55-8. PubMed ID: 12652959 [Abstract] [Full Text] [Related]
13. Clinical inquiries. Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD? McDiarmid T, Mackler L, Briscoe D. J Fam Pract; 2003 Dec 01; 52(12):979-80. PubMed ID: 14653988 [No Abstract] [Full Text] [Related]
14. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N, Tertemiz KC, Sevinç C. Tuberk Toraks; 2008 Dec 01; 56(4):382-9. PubMed ID: 19123073 [Abstract] [Full Text] [Related]
15. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Respir Med; 2008 Aug 01; 102(8):1099-108. PubMed ID: 18614347 [Abstract] [Full Text] [Related]
16. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)]. Gillissen A, Gessner C, Hoheisel G, Juergens U. Pneumologie; 2008 Jul 01; 62(7):430-7. PubMed ID: 18398787 [Abstract] [Full Text] [Related]
17. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases]. Ieda Y, Nagasaka Y. Clin Calcium; 2007 Jun 01; 17(6):955-62. PubMed ID: 17548937 [Abstract] [Full Text] [Related]
18. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS. Respir Med; 2007 Dec 01; 101(12):2464-71. PubMed ID: 17719763 [Abstract] [Full Text] [Related]
19. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD. Groenewegen KH, Dentener MA, Wouters EF. Respir Med; 2007 Nov 01; 101(11):2409-15. PubMed ID: 17644367 [Abstract] [Full Text] [Related]
20. [New pharmacological options in the therapy of COPD]. Watz H, Kanniess F, Magnussen H. Pneumologie; 2007 Jun 01; 61(6):365-73. PubMed ID: 17492578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]